Peroxisonte proliferator-activated receptor-γ regulates expression of PDX-1 and NKX6.1 in INS-1 cells

被引:63
作者
Moibi, Jacob A.
Gupta, Dhananjay
Jetton, Thomas L.
Peshavaria, Mina
Desai, Ronak
Leahy, Jack L.
机构
[1] Univ Vermont, Coll Med, Dept Med, Div Endocrinol Diabet & Metab, Burlington, VT 05405 USA
[2] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada
关键词
D O I
10.2337/db06-0948
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the 60% pancreatectomy (Px) rat model of beta-cell adaptation, normoglycemia is maintained by an initial week of beta-cell hyperplasia that ceases and is followed by enhanced beta-cell function. It is unknown how this complex series of events is regulated. We studied isolated islets and pancreas sections from 14-day post-Px versus sham-operated rats and observed a doubling of beta-cell nuclear peroxisome proliferator-activated receptor (PPAR)-gamma protein, along with a 2-fold increase in nuclear pancreatic duodenal homeobox (Pdx)-1 protein and a 1.4-fold increase in beta-cell nuclear Nkx6.1 immunostaining. As PPAR-gamma activation is known to both lower proliferation and have prodifferentiation effects in many tissues, we studied PPAR-gamma actions in INS-1 cells. A 3-day incubation with the PPAR-gamma agonist troglitazone reduced proliferation and increased Pdx-1 and Nkx6.1 immunostaining, along with glucokinase and GLUT2. Also, a 75% knockdown of PPAR-gamma using RNA interference lowered the mRNA levels of Pdx-1, glucokinase, GLUT2, and proinsulin 11 by more than half. Our results show a dual effect of PPAR-gamma in INS-1 cells: to curtail proliferation and promote maturation, the latter via enhanced expression of Pdx-1 and Nkx6.1. Additional studies are needed to determine whether there is a regulatory role for PPAR-gamma signaling in the beta-cell adaptation following a 60% Px in rats.
引用
收藏
页码:88 / 95
页数:8
相关论文
共 51 条
[1]   β-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes [J].
Ahlgren, U ;
Jonsson, J ;
Jonsson, L ;
Simu, K ;
Edlund, H .
GENES & DEVELOPMENT, 1998, 12 (12) :1763-1768
[2]   Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat [J].
Braissant, O ;
Foufelle, F ;
Scotto, C ;
Dauca, M ;
Wahli, W .
ENDOCRINOLOGY, 1996, 137 (01) :354-366
[3]   Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis [J].
Brissova, M ;
Blaha, M ;
Spear, C ;
Nicholson, W ;
Radhika, A ;
Shiota, M ;
Charron, MJ ;
Wright, CVE ;
Powers, AC .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 288 (04) :E707-E714
[4]   Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion [J].
Brissova, M ;
Shiota, M ;
Nicholson, WE ;
Gannon, M ;
Knobel, SM ;
Piston, DW ;
Wright, CVE ;
Powers, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :11225-11232
[5]   Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women [J].
Buchanan, TA ;
Xiang, AH ;
Peters, RK ;
Kjos, SL ;
Marroquin, A ;
Goico, J ;
Ochoa, C ;
Tan, S ;
Berkowitz, K ;
Hodis, HN ;
Azen, SP .
DIABETES, 2002, 51 (09) :2796-2803
[6]   Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-γ ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation [J].
de Dios, ST ;
Bruemmer, D ;
Dilley, RJ ;
Ivey, ME ;
Jennings, GLR ;
Law, RE ;
Little, PJ .
CIRCULATION, 2003, 107 (20) :2548-2550
[7]   Expression of peroxisome proliferator-activated receptor γ (PPARγ) in normal human pancreatic islet cells [J].
Dubois, M ;
Pattou, F ;
Kerr-Conte, J ;
Gmyr, V ;
Vandewalle, B ;
Desreumaux, P ;
Auwerx, J ;
Schoonjans, K ;
Lefebvre, J .
DIABETOLOGIA, 2000, 43 (09) :1165-1169
[8]   β-cell mass dynamics in Zucker diabetic fatty rats -: Rosiglitazone prevents the rise in net cell death [J].
Finegood, DT ;
McArthur, MD ;
Kojwang, D ;
Thomas, MJ ;
Topp, BG ;
Leonard, T ;
Buckingham, RE .
DIABETES, 2001, 50 (05) :1021-1029
[9]   Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture [J].
Fröhlich, E ;
Machicao, F ;
Wahl, R .
ENDOCRINE-RELATED CANCER, 2005, 12 (02) :291-303
[10]   Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial [J].
Gerstein, H. C. ;
Yusuf, S. ;
Holman, R. R. ;
Bosch, J. ;
Anand, S. ;
Avezum, A. ;
Budaj, A. ;
Chiasson, J. ;
Conget, I. ;
Dagenais, G. ;
Davis, M. ;
Diaz, R. ;
Dinccag, N. ;
Enjalbert, M. ;
Escalante, A. ;
Fodor, G. ;
Hanefeld, M. ;
Hedner, T. ;
Jolly, K. ;
Keltai, M. ;
Laakso, M. ;
Lanas, F. ;
Lonn, E. ;
McQueen, M. ;
Mohan, V. ;
Phillips, A. ;
Piegas, L. ;
Pirags, V. ;
Probstfield, J. ;
Shaw, J. ;
Schmid, I. ;
Teo, K. ;
Zimmet, P. ;
Zinman, B. ;
Gerstein, H. C. ;
Yusuf, S. ;
Bosch, J. ;
Pogue, J. ;
Sheridan, P. ;
Dinccag, N. ;
Hanefeld, M. ;
Hoogwerf, B. ;
Laakso, M. ;
Mohan, V. ;
Shaw, J. ;
Zinman, B. ;
Holman, R. R. ;
Diaz, R. ;
Ahuad Guerrero, R. ;
Albisu, J. .
LANCET, 2006, 368 (9541) :1096-1105